SCOPUS 정보 검색 플랫폼

Genetic Engineering News

Volumn 23, Issue 3, 2003, Pages 28-29

Direct binding assays for pharma screening

(2) Todd, Matthew J a Salemme, F Raymond b

a ThermoFluor Technology (United States)

b 3 Dimensional Pharmaceuticals (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR; GLYCEROL; LIGAND; MACROGOL; OXAMIC ACID; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; REDUCING AGENT; SURFACTANT;

BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CALORIMETRY; CELL ASSAY; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG DESIGN; DRUG INDUSTRY; DRUG SCREENING; ENTHALPY; ENZYMOLOGY; FLUORESCENCE; LIGAND BINDING; LIGHT SCATTERING; NOTE; PH; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STABILITY; STOICHIOMETRY; TECHNOLOGY; TEMPERATURE DEPENDENCE; THERMOSTABILITY;

EID: 0037308319 PISSN: 02706377 EISSN: None Source Type: Journal
DOI: None Document Type: Note

Times cited : (22)

References (5)

1
- 0023068366
- The thermodynamic stability of proteins
- J.A. Shellman. The Thermodynamic Stability of Proteins. Ann. Rev. Biophys. Chem. 16, 115-137 (1987).
- (1987) Ann. Rev. Biophys. Chem. , vol.16 , pp. 115-137
- Shellman, J.A.¹

2
- 18244380348
- High-density miniaturized thermal-shift assays as a general strategy for drug discovery
- M. W. Pantoliano, E. C. Petrella, J. D. Kwasnoski, V. S. Lobanov, J. Myslik, E. Graf, T. Carver, E. Asel, B. A. Springer, P. Lane, and F. R. Salemme. "High-density miniaturized thermal-shift assays as a general strategy for drug discovery." J Biomol. Screen 6:429-40 (2001).
- (2001) J. Biomol. Screen , vol.6 , pp. 429-440
- Pantoliano, M.W.¹ Petrella, E.C.² Kwasnoski, J.D.³ Lobanov, V.S.⁴ Myslik, J.⁵ Graf, E.⁶ Carver, T.⁷ Asel, E.⁸ Springer, B.A.⁹ Lane, P.¹⁰ Salemme, F.R.¹¹

3
- 0037061628
- A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
- S. L. McGovern, E. Caselli, N. Grigorieff, & B.K. Shoichet. "A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening." J. Med. Chem. 11:1712-22 (2002).
- (2002) J. Med. Chem. , vol.11 , pp. 1712-1722
- McGovern, S.L.¹ Caselli, E.² Grigorieff, N.³ Shoichet, B.K.⁴

4
- 0034629107
- 2-(Oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases
- H. S. Andersen, L. F. Iversen, C. B. Jeppensen, S. Branner, K. Norris, H. B. Rasmussen, K. B. Møller, & N. P. H. Møller, "2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases." J. Biol. Chem. 275:7101-7108.
- J. Biol. Chem. , vol.275 , pp. 7101-7108
- Andersen, H.S.¹ Iversen, L.F.² Jeppensen, C.B.³ Branner, S.⁴ Norris, K.⁵ Rasmussen, H.B.⁶ Møller, K.B.⁷ Møller, N.P.H.⁸

5
- 13044270997
- PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-Arylbenzo[b] naptho[2,3-d]furans and 11-Arylbenzo[b] naptho[2,3-d]thiophenes
- J. Wrobel, J. Sredy, C. Moxham, A. Dietrich, Z. Li, D. R. Sawicki, L. Seestaller, L. Wu, A. Katz, D. Sullivan, C. Tio, & Z-Y Zhang. PTP1B Inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-Arylbenzo[b] naptho[2,3-d]furans and 11-Arylbenzo[b] naptho[2,3-d]thiophenes. J. Med. Chem. 42:3199-3202 (1999).
- (1999) J. Med. Chem. , vol.42 , pp. 3199-3202
- Wrobel, J.¹ Sredy, J.² Moxham, C.³ Dietrich, A.⁴ Li, Z.⁵ Sawicki, D.R.⁶ Seestaller, L.⁷ Wu, L.⁸ Katz, A.⁹ Sullivan, D.¹⁰ Tio, C.¹¹ Zhang, Z.-Y.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.